Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 24
Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
Yamin Shu, Yiling Ding, Lulu Liu, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 9, pp. 2705-2716
Open Access | Times Cited: 18
Cardiovascular toxicity induced by SSRIs: Analysis of spontaneous reports submitted to FAERS
Yukun Chen, Qingze Fan, Yang Liu, et al.
Psychiatry Research (2023) Vol. 326, pp. 115300-115300
Closed Access | Times Cited: 17
Drug-induced cardiac toxicity and adverse drug reactions, a narrative review
Alexandre Destère, Diane Merino, Thibaud Lavrut, et al.
Therapies (2023) Vol. 79, Iss. 2, pp. 161-172
Closed Access | Times Cited: 12
Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
Dongxuan Li, Shuang Chai, Hongli Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)
Luyao He, Mengting Shen, Lei Zhang, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Cardiac Considerations in Treatment of Schizophrenia: A Case Report Highlighting the Use of Long-acting Injection Paliperidone Palmitate Depot in Schizophrenia Patient with Comorbid Wolff-Parkinson-White Syndrome
Suparna Kumar, Sangha Mitra Godi
Indian Journal of Private Psychiatry (2025) Vol. 19, Iss. 1, pp. 48-50
Open Access
Acute Exposure to Clozapine and Sodium Valproate Impairs Oxidative Phosphorylation in Human Cardiac Mitochondria
Amanda Groenewald, Kathryn Burns, Malcolm D. Tingle, et al.
Toxicology Reports (2025) Vol. 14, pp. 101990-101990
Open Access
Schizophrenia and Related Psychoses

(2025), pp. 1-278
Closed Access
Evaluation of Global Dystonia Rating Scale as a predictor of unfavorable outcomes among acute antipsychotics poisoned patients
Asmaa Fady Sharif, Zahraa Khalifa Sobh, Sanaa Abd El‐Fatah Abdo, et al.
Drug and Chemical Toxicology (2024) Vol. 47, Iss. 4, pp. 386-403
Closed Access | Times Cited: 3
Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia
Zerui Hu, Zhenzhen Yang, Xubo Wang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 3
Possible adverse events of imidazole antifungal drugs during treatment of vulvovaginal candidiasis: analysis of the FDA Adverse Event Reporting System
Tianyu Zhou, Chongze Chen, X Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Drug-induced noninfectious myocarditis: a disproportionality analysis of the FAERS database
Liyuan Yan, Guanqun Zheng
Expert Opinion on Drug Safety (2024), pp. 1-9
Closed Access
Amisulpride-Associated QTc Prolongation
Sanjana Kathiravan, Arshia Sood, Sandeep Grover
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 3, pp. 302-303
Closed Access | Times Cited: 1
Page 1

Scroll to top